In August, the U.S. Food and Drug Administration approved the new COVID-19 booster shots, but with certain restrictions.

Community-acquired pneumonia is a major global health challenge that disproportionately affects vulnerable populations, including older people, immunocompromised people, those with chronic conditions, ...